1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
48.13%
Revenue growth above 1.5x SEDG's 22.38%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
268.96%
Gross profit growth above 1.5x SEDG's 23.35%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
22.43%
EBIT growth below 50% of SEDG's 46.81%. Michael Burry would suspect deeper competitive or cost structure issues.
7.68%
Operating income growth under 50% of SEDG's 32.86%. Michael Burry would be concerned about deeper cost or sales issues.
42.14%
Net income growth above 1.5x SEDG's 24.18%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
41.79%
EPS growth above 1.5x SEDG's 22.22%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
41.79%
Diluted EPS growth above 1.5x SEDG's 22.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.05%
Share reduction more than 1.5x SEDG's 1.73%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.05%
Diluted share reduction more than 1.5x SEDG's 2.90%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
83.55%
OCF growth above 1.5x SEDG's 6.05%. David Dodd would confirm a clear edge in underlying cash generation.
54.77%
FCF growth above 1.5x SEDG's 7.96%. David Dodd would verify if the firm’s strategic investments yield superior returns.
15.45%
Positive 10Y revenue/share CAGR while SEDG is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-36.17%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-31.06%
Negative 3Y CAGR while SEDG stands at 74.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-6.52%
Negative 10Y OCF/share CAGR while SEDG stands at 158.28%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
28.49%
Below 50% of SEDG's 158.28%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
22.80%
3Y OCF/share CAGR under 50% of SEDG's 9199.60%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-458.30%
Negative 10Y net income/share CAGR while SEDG is at 134.56%. Joel Greenblatt sees a major red flag in long-term profit erosion.
4.71%
Below 50% of SEDG's 134.56%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-259.26%
Negative 3Y CAGR while SEDG is 676.96%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-53.50%
Negative equity/share CAGR over 10 years while SEDG stands at 380.15%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-46.51%
Negative 5Y equity/share growth while SEDG is at 380.15%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-52.35%
Negative 3Y equity/share growth while SEDG is at 3671.53%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.82%
AR growth is negative/stable vs. SEDG's 14.83%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-8.26%
Inventory is declining while SEDG stands at 10.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.10%
Negative asset growth while SEDG invests at 11.53%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.89%
We have a declining book value while SEDG shows 8.34%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
18.11%
Debt growth of 18.11% while SEDG is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
4.75%
R&D dropping or stable vs. SEDG's 12.87%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-0.44%
We cut SG&A while SEDG invests at 20.16%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.